We are live on
!
Find out more
GPCM
Granite Point Capital Management Portfolio holdings
AUM
$4.9M
1-Year Est. Return
38.41%
This Fund
S&P 500
This Quarter
Est. Return
+53.63%
1 Year Est. Return
+38.41%
3 Year Est. Return
+124.67%
5 Year Est. Return
+295.96%
10 Year Est. Return
–
AUM
$1.96B
AUM Growth
+$1.79B
(+1,009%)
Cap. Flow
+$1.58B
Cap. Flow
% of AUM
80.63%
Top 10 Holdings %
Top 10 Hldgs %
70.73%
Holding
163
New
90
Increased
15
Reduced
16
Closed
23
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SLNO
Soleno Therapeutics
SLNO
|
+$6.36M |
| 2 |
Magnite
MGNI
|
+$5.64M |
| 3 |
EVRI
Everi Holdings
EVRI
|
+$4.32M |
| 4 |
SIEN
Sientra, Inc.
SIEN
|
+$4.24M |
| 5 |
MNTV
Momentive Global Inc. Common Stock
MNTV
|
+$4.01M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$6.76M |
| 2 |
VanEck Gold Miners ETF
GDX
|
+$5.59M |
| 3 |
DraftKings
DKNG
|
+$3.32M |
| 4 |
Teekay
TK
|
+$2.94M |
| 5 |
GTLS
Chart Industries
GTLS
|
+$2.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.12% |
| 2 | Consumer Discretionary | 2.18% |
| 3 | Communication Services | 1.15% |
| 4 | Technology | 1.11% |
| 5 | Financials | 0.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Immunic
IMUX
$198M
| $2.4M | 0.12% |
+19,803
| New | +$2.01M |
|
77
Arcturus Therapeutics
ARCT
$173M
| $2.34M | 0.12% |
+50,000
| New | +$1.72M |
|
78
Alibaba
BABA
$304B
| $2.27M | 0.12% |
10,500
-3,000
| -22% | -$625K |
|
79
Zumiez
ZUMZ
$332M
| $2.19M | 0.11% |
+80,000
| New | +$1.82M |
|
80
Micron Technology
MU
$996B
| $2.15M | 0.11% |
41,735
-22,265
| -35% | -$1.05M |
|
81
Boston Beer
SAM
$1.88B
| $2.15M | 0.11% |
4,000
+1,000
| +33% | +$484K |
|
82
PUT
Invesco Mortgage Capital
IVR
$758M
| $2.12M | 0.11% |
+56,630
| New | +$1.95M |
|
83
Immatics
IMTX
$1.29B
| $1.97M | 0.1% |
+125,000
| New | +$1.53M |
|
84
Sea Limited
SE
$68B
| $1.89M | 0.1% |
17,600
-10,000
| -36% | -$724K |
|
|
WBT
85
CALL
DELISTED
Welbilt, Inc.
WBT
| $1.83M | 0.09% |
+300,000
| New | +$1.62M |
|
|
CHMI
86
Cherry Hill Mortgage Investment Corp
CHMI
$87.8M
| $1.8M | 0.09% |
+200,000
| New | +$1.54M |
|
87
Xenon Pharmaceuticals
XENE
$6.24B
| $1.78M | 0.09% |
141,660
| – | – |
|
88
Corbus Pharmaceuticals
CRBP
$180M
| $1.68M | 0.09% |
+6,667
| New | +$1.35M |
|
|
LADR
89
Ladder Capital
LADR
$1.21B
| $1.62M | 0.08% |
+200,000
| New | +$1.5M |
|
90
Altimmune
ALT
$585M
| $1.61M | 0.08% |
+150,000
| New | +$824K |
|
91
RingCentral
RNG
$5.18B
| $1.57M | 0.08% |
5,525
| – | – |
|
|
TCRR
92
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $1.54M | 0.08% |
+100,000
| New | +$1.15M |
|
93
Boeing
BA
$184B
| $1.47M | 0.07% |
8,000
-2,000
| -20% | -$307K |
|
94
Celldex Therapeutics
CLDX
$3.26B
| $1.42M | 0.07% |
+109,095
| New | +$484K |
|
95
CareDx
CDNA
$2.32B
| $1.42M | 0.07% |
40,000
| – | – |
|
96
JPMorgan Chase
JPM
$947B
| $1.41M | 0.07% |
15,000
| – | – |
|
|
SDC
97
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
| $1.41M | 0.07% |
+178,500
| New | +$1.21M |
|
|
LPRO
98
DELISTED
Open Lending Corp
LPRO
| $1.36M | 0.07% |
+90,000
| New | +$1.02M |
|
|
ROCHU
99
DELISTED
Roth CH Acquisition I Co. Unit
ROCHU
| $1.36M | 0.07% |
+135,000
| New | +$1.35M |
|
100
Immunovant
IMVT
$8.2B
| $1.22M | 0.06% |
50,000
+15,000
| +43% | +$321K |
|
Similar funds
MAM
CCM
BGCI
CAM
EAM
SM
TPL
RC
Granite Point Capital Management's Q2 2020 Portfolio in Review
As of Q2 2020, Granite Point Capital Management held 163 positions worth $1.96B, up 1,009% from $177M the previous quarter. Its ten largest holdings account for 71% of the portfolio.
Granite Point Capital Management deployed $1.58B of net new capital in Q2 2020, opening 90 new positions and adding to 15 existing holdings. Its largest new stake was Soleno Therapeutics: 146,667 shares worth $4.88M.
By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, down from 13% a quarter earlier, followed by Consumer Discretionary and Communication Services.
On the sell side, the largest reduction was Amazon, an estimated $6.76M trimmed.
- Granite Point Capital Management's largest Q2 2020 buy was Soleno Therapeutics: 146,667 shares worth $4.88M.
- Granite Point Capital Management added most to Sientra, Inc. in Q2 2020, an estimated $4.24M increase.
- Granite Point Capital Management's biggest Q2 2020 reduction was Amazon, cutting an estimated $6.76M.
- Granite Point Capital Management fully exited Teekay in Q2 2020, selling an estimated $2.94M.
- Granite Point Capital Management's ten largest holdings make up 71% of its $1.96B portfolio in Q2 2020.
- Granite Point Capital Management opened 90 new positions and closed 23 in Q2 2020.
- Granite Point Capital Management's portfolio value rose 1,009% quarter-over-quarter to $1.96B.
Based on Granite Point Capital Management's 13F filing for Q2 2020, filed 12 Aug 2020.